Cervical cancer screening for my community medicine exam from park textbook
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
This is very comprehensive. I now have all the key content from Park's textbook. Let me compile this into a thorough exam-focused answer.
Cervical Cancer Screening - Park's Textbook of Preventive and Social Medicine
1. Magnitude of the Problem
- Cervical cancer is the 4th most frequent cancer in women globally (6,04,000 new cases in 2020 = 6.6% of all female cancers)
- ~3,42,000 deaths/year; 90% of deaths occur in low- and middle-income countries
- In India: 9.4% of all cancers in women; age-standardized incidence ~18.0 per 1,00,000; estimated 77,348 deaths in 2020
- Marked decline in incidence in industrialized countries - largely due to extensive screening programmes
2. Natural History (Basis for Screening)
Cervical cancer follows a progressive, predictable course, making it ideal for screening:
Normal Epithelium → Dysplasia → Carcinoma in Situ → Invasive Carcinoma
- Carcinoma in situ persists > 8 years on average before becoming invasive
- Progression to invasive carcinoma may average 15-20 years from the preinvasive stage
- Some in situ cases will spontaneously regress without treatment
- This long preinvasive window is the scientific rationale for screening
3. Causative Agent
- Human Papillomavirus (HPV) - sexually transmitted
- Found in >95% of cervical cancers
- HPV is a necessary but not sufficient cause - other co-factors also involved
- High-risk HPV types: 16, 18, 31, 45 (and others)
4. Risk Factors
| Risk Factor | Details |
|---|---|
| Age | Incidence rises rapidly from 25-45 years |
| Genital warts | Past/present occurrence - important risk factor |
| Marital status | More common in widowed, divorced, separated; multiple sexual partners |
| Sexual activity | Very common in prostitutes; practically unknown in virgins |
| Early marriage | Early coitus, early childbearing, repeated childbirth |
| OCP use | Renewed concern about link with invasive cervical cancer |
| HPV infection | Most critical risk factor |
5. Screening - The Pap Smear (Papanicolaou Test)
Definition of Cancer Screening (Park)
"The search for unrecognized malignancy by means of rapidly applied tests."
Pap Smear - The Primary Tool
- Cervical cancer screening has become an accepted clinical practice
- Pap smear detects the prolonged early phase of cancer in situ
Recommended Schedule (Park's)
| Recommendation | Details |
|---|---|
| Initial screening | All women should have a Pap test (cervical smear) at the start of sexual activity or at age 20-25 |
| Frequency | Annually or every 3 years after two consecutive normal smears |
| High-risk women | Annual smear recommended |
| Upper age limit | Up to 60-65 years |
| Low-risk (never sexually active) | Screening may not be required |
How the Pap Smear Works
- Cells are scraped from the cervical transformation zone (squamocolumnar junction)
- Smear is examined cytologically for dysplastic/malignant cells
- Classified by the Bethesda System (LSIL, HSIL, ASCUS, etc.)
6. Other Screening Methods
| Method | Features |
|---|---|
| VIA (Visual Inspection with Acetic Acid) | Acetic acid applied to cervix; acetowhite lesions indicate abnormality; low cost, suitable for low-resource settings |
| VILI (Visual Inspection with Lugol's Iodine) | Iodine applied; non-staining (iodine negative) areas are suspicious |
| HPV DNA Testing | Detects high-risk HPV strains; can be used alone (primary screening) or as co-test with Pap smear; especially useful in women 30 years and older |
| Colposcopy | For follow-up of abnormal Pap smears; directed biopsy |
VIA - Key Points for Exam
- Simple, cheap, no lab required - ideal for primary health care level in India
- "See and treat" approach possible (cryotherapy at same visit)
- Sensitivity ~70-80%, specificity ~85%
- WHO-recommended for low-resource countries
7. Cancer Screening Principles (Wilson & Jungner Criteria) - as applied to Cervical Cancer
Cervical cancer satisfies screening criteria because:
- It is an important health problem (high burden in India)
- There is an accepted latent/early symptomatic stage (CIN - Cervical Intraepithelial Neoplasia)
- Suitable test available (Pap smear, VIA, HPV testing)
- Facilities for diagnosis and treatment exist
- Natural history is adequately understood
- There is an agreed policy on whom to treat
- Cost of case-finding is economically balanced
8. India-Specific: National Programmes
- NPCDCS (National Programme for Prevention and Control of Cancer, Diabetes, CVD and Stroke): Includes screening for cervical, breast, and oral cancers
- Screening for cervical cancer is among the coverage indicators tracked under SDG 3 (SDG 3.1 related targets)
- Focus on VIA-based screening at PHC level in India
9. Primary Prevention (Complement to Screening)
- HPV Vaccination (Gardasil, Cervarix): Protects against HPV types 16 and 18
- Recommended for girls 9-14 years (before sexual debut) for maximum efficacy
- Does not replace Pap smear screening - vaccinated women still need screening
10. Quick-Recall Summary Table
| Feature | Key Fact |
|---|---|
| Screening test | Pap smear (gold standard) |
| Alternative (low-resource) | VIA, VILI |
| Causative agent | HPV (>95% cases) |
| Age to start | 20-25 years or at sexual debut |
| Frequency | Every 1-3 years |
| Stop age | 60-65 years |
| Pre-invasive duration | >8 years (avg) |
| Progression to invasive | 15-20 years |
| India incidence | 9.4% of all female cancers |
| India deaths (2020) | 77,348 |
Source: Park's Textbook of Preventive and Social Medicine (Chapter on Cancer - Cancer Cervix and Cancer Screening sections)
Exam Tip: Park consistently emphasizes that the long preinvasive phase of cancer cervix (>8 years in situ) is what makes Pap smear screening scientifically valid and effective. VIA is the WHO/India-recommended tool for low-resource settings, and the "see and treat" approach is a key concept.
This is a shared conversation. Sign in to Orris to start your own chat.